Most hyper-functioning tumors harbor both TSHR mutations and proto-oncogene mutations; this coexistence suggests that carcinomas arise from the activity of classical oncogenes, such as RAS and RET/PTC, and that the TSHR and Gs mutations contribute to the hyper-functioning features of the neoplasms. The gene discussed is TSHR; the disease is neoplasm.